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Abstract
Objectives: Iron depletion is common around the world and among certain risk
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serving as reference method. Blood was also collected from the fingertip using the
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novel plasma collection card for minimally invasive iron status assessment.
Ferritin and hemoglobin were measured from blood collected from a forearm vein,
NoviplexTM Plasma Prep Card as well as capillary collection tubes.
Results: There was substantial concordance between ferritin measured from samples collected via NoviplexTM and venous ferritin (concordance correlation coefficient (CCC) = 0.96) with a mean bias of −0.8 ng/mL. Storing NoviplexTM cards at room
temperature for 2 weeks resulted in slightly lower but good concordance when compared to venous ferritin (CCC = 0.95). Capillary hemoglobin (CCC = 0.42) and hematocrit (CCC = 0.25) were in poor agreement with venous data.
Conclusions: NoviplexTM cards offer a suitable alternative for a minimally invasive
ferritin screening in the field when compared to capillary collection tubes. Despite
overall substantial concordance with the reference method, findings indicative of
iron status abnormalities should be confirmed in venous samples.
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1 | I NTRO D U C TI O N

losses through various mechanisms, including excessive sweating,
gastrointestinal bleeding, hemolysis, and exercise-induced inflam-

Iron deficiency is one of the most common nutrient deficiencies

mation.4-6 As a result, athletes are almost three times as likely to be

worldwide.1 Although the overall prevalence of iron deficiency ane-

iron depleted when compared to non-athletes,7 a risk that is even

2

further exacerbated in certain groups, such as female adolescent

certain subgroups are at increased risk for iron status disorders. One

athletes, among whom as much as 58% may suffer from iron deple-

group for whom iron is a particularly critical micronutrient are ath-

tion.7,8 Iron depletion, even in the absence of anemia, can result in

letes and recreational exercisers,3 who experience increased iron

suboptimal athletic performance,9-11 which can be reversed by means

mia (IDA) is low in the United States and other developed countries,

This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction
in any medium, provided the original work is properly cited and is not used for commercial purposes.
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of iron supplementation or dietary intervention.12-16 Considering the
wide-spread prevalence of iron status abnormalities among athletes
and its detrimental effects on performance, along with the potential

Novelty Statement

dangerous side effects of unmonitored supplementation,6 regular

• We tested a novel methodology for plasma collection

screening and monitoring of iron status are common practice among

with regard to its suitability for minimally invasive fer-

17

athletes.

The most common screening measure of iron status is

plasma ferritin, which is reflective of iron storage, along with hemoglobin and hematocrit reflecting functional iron in red blood cells.11
Routinely, these markers are assessed from blood samples obtained via venous blood sampling. However, venous sampling is in-

ritin assessment.
• Our central finding is that NoviplexTM PLasma Prep
Cards provide acceptable concordance with the reference method of venous sampling, even when cards are
stored for a prolonged time prior to analysis.

vasive, costly, demanding in terms of equipment and requires highly

• NoviplexTM prep cards are suitable for minimally inva-

trained and certified personnel. When compared to other forms of

sive sample iron status screening, particularly in settings

sample collection, it is more likely to result in adverse events for

outside of the laboratory.

subjects and healthcare workers and involves greater sampling
volumes.18 Further, phlebotomy-related issues are regarded the
primary source of errors occurring in the pre-analytical phase.19
An alternative sampling method involves the collection of capillary
20

methodologies, our overall goal was to test the suitability of these

and

cards for minimally invasive assessment of iron status biomarkers.

has been used for the assessment of iron status markers in various

The purpose of the present proof-of-concept study was to assess the

vulnerable populations. 21-23 In one of the few studies on the validity

validity of ferritin concentrations in plasma samples collected using

of capillary iron markers, capillary measurements of ferritin were

the NoviplexTM system in comparison with plasma samples obtained

found to be ~3%-5% higher and more variable when compared to

via venous blood collection, the clinical gold standard. To control for

blood, which is considered more applicable in field settings

venous blood, although the authors concluded that these issues

potential differences in collection sites, we further assessed iron sta-

were outweighed by the benefits of using capillary over venous

tus measures in traditionally collected capillary samples.

blood collection. 24
Despite this favorable cost-benefit profile, traditional capillary
sampling faces challenges similar to venous sampling, such as the

2 | M E TH O DS

need to separate plasma from red blood cells, refrigeration, and
transport under biosafety guidelines. Due to these limitations, nu-

The present proof-of-concept study was conducted as a cross-sec-

merous attempts have been made to collect blood in the field for

tional comparison of capillary and venous markers of iron status in

screening purposes using methods that do not require laborato-

a convenience sample of adults (Figure 1). All procedures were ap-

ry-intensive sample preparation and handling. 20 The most promis-

proved in advance by our university's Institutional Review Board. All

ing approach involves blood spots, which have been used by various

participants provided written consent prior to data and blood sam-

18,25

groups to measure ferritin.

These blood spots, which are typi-

ple collection.

cally collected on filter paper and can be stored without freezing,
reduce burden and cost for sample transport and storage. However,
blood spots collected on filter paper require precise knowledge of

2.1 | Participants

the blood volume and extensive sample processing involving incubation with cellulase prior to analysis.18,25 Furthermore, the com-

Participants were recruited locally via word by mouth and fliers.

plete separation of plasma from red blood cells is critical for valid

Volunteers were included if they were between 19 and 65 years

assessments of ferritin, as ferritin is present both in plasma and in

of age and non-pregnant. Participants were excluded if they had

red blood cells, albeit at much higher concentrations in the latter,

a history of any disease that affects red blood cell morphology or

which bears the risk of masking the presence of iron depletion or

felt unable to complete venous and/or capillary blood collection.

deficiency when cellular ferritin leaks into plasma or whole blood

Demographic data and information pertaining to inclusion and ex-

is analyzed. 20

clusion criteria were collected by self-report using a short survey.

These challenges can be overcome using a novel plasma collection card, the Noviplex™ Plasma Prep Card (Novilytic, West

Upon inclusion into the study, height and weight were collected
using a scale and stadiometer (Seca, Hamburg, Germany).

Lafayette, IN). These cards consist of a precut absorbent collection
disk underneath a membrane filter. Blood can be collected directly
onto the card test area and exact aliquots of plasma are drawn

2.2 | Sample collection

through the filter by capillary action, reducing the likelihood of hemolysis and removing the need for equipment such as pipettes and

Blood samples were obtained by a trained phlebotomist via veni-

centrifuges. Given these benefits over more traditional sampling

puncture and capillary collection. Venous blood (6 mL) was collected

556
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FIGURE 1
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Schematic depiction of the study protocol

from an antecubital vein into EDTA-coated tubes (BD Vacutainer®).

2.4 | Assessments

Capillary blood (600 µL) was collected via finger prick using a disposable lancet (SurgiLance™, 2.3 mm depth). The first droplet of blood was

Plasma concentrations of ferritin were determined using commer-

wiped away, and gentle pressure was applied to collect blood into an

cially available ELISA kits (Ferritin: #S-22; Ramco Laboratories, Inc,

EDTA-coated capillary tube (Sarstedt Microvette) and directly onto

Houston, TX). ELISAs were performed by the same laboratory tech-

the test area of a total of two Noviplex™ Plasma Prep Cards (Novilytic,

nician as per manufacturer instructions. Venous and capillary sam-

North Webster, IN). For the assessment of ferritin, we used Noviplex™

ples collected via capillary tubes were analyzed in duplicate and data

UNO cards, which collect 2.5 µL of plasma onto one collection disk.

are reported as the mean of the duplicate analysis. Recovered plasma

Noviplex™ Plasma Prep Cards have a control indicator which signals

from Noviplex™ Plasma Prep Cards was analyzed in singlet. The limit

when sufficient volume of sample has been applied. After 3 minutes,

of detection was 0.59 ng/mL and assay precision in our laboratory

the top layer of the card containing the filter used to separate plasma

was <8.0% for duplicate samples. For one participant, ferritin data

from blood cells was removed, and the bottom layer containing the ab-

are missing for both immediate and delayed analyses of the Plasma

sorbent collection disk was allowed to dry for 15 minutes prior to fur-

Prep Card because assay results fell below the limit of detection. For

ther analysis. In order to assess the stability of ferritin using Noviplex™

another participant, ferritin data are missing only for delayed analysis

cards, one card was processed immediately (immediate analysis), and

due to a technical error. For venous and capillary blood, we further

an additional card was stored at room temperature for 14 days prior to

collected whole-blood measurements of hemoglobin (Hb) and hema-

further processing (delayed analysis).

tocrit (Hct), which were taken at the time of draw using a handheld
AimStrip® Hb Meter (Germaine™ Laboratories, San Antonio, TX).

2.3 | Sample processing

As an additional reference, Hb and Hct were also measured using a
hematology analyzer (QBC Autoread Plus, QBC, Port Matilda, PA),
although this measurement was conducted on venous samples only.

Venous blood samples as well as capillary tubes were centrifuged
for 10 minutes at 1972 g to separate plasma and red blood cells.
After centrifugation, plasma was transferred into microcentrifuge

2.5 | Data analysis and statistics

tubes and stored at −80°C until the time of analysis. For Noviplex™
cards, plasma was recovered from the collection disk using 25 µL

To assess the validity of Noviplex™ Plasma Prep Cards for ferritin, we

of phosphate-buffered saline (pH 7.4) by agitation for 10 minutes

compared ferritin measured from samples collected with cards to ferri-

using a Gyrotory shaker (New Brunswick Scientific, Edison, NJ). The

tin measured from samples collected via venous blood sampling, which

recovered plasma was stored at −80°C until the time of analysis.

served as the reference method. To account for differences in collection

Concentrations were subsequently corrected for the volume differ-

sites (capillary vs. venous) and collection techniques (cards vs. tubes), we

ence in collection and recovery.

further compared ferritin data between samples collected via capillary

|
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tubes and venous collection and between samples collected via cards

standard, ferritin measured from venous blood samples (Figure 2).

and capillary tubes. We also compared whole-blood-based markers of

Bland-Altman analysis revealed no systematic bias (mean differ-

iron status (hemoglobin and hematocrit) from capillary and venous sam-

ence = −0.8 ng/mL) with upper and lower limits of agreements

ples using a handheld analyzer. To account for possible errors of our

ranging from −23.0 to 21.3 ng/mL. The total error between plasma

handheld hematology device, we lastly compared hemoglobin and he-

ferritin measured with NoviplexTM cards and venous ferritin ex-

matocrit data collected using the handheld analyzer with data assessed

ceeded the recommended desirable range of 16.9% in 8 samples

with our laboratory-based hematology analyzer (venous samples only).

(40%). Because the accurate assessment of ferritin near the thresh-

Statistical analyses were conducted using R version 3.6.1 (The

olds for iron depletion (25 ng/mL) and iron deficiency (12 ng/mL) is

R Foundation for Statistical Computing, 2019). Precision and accu-

particularly critical, a separate analysis was conducted utilizing only

racy were determined using the concordance correlation coefficient

data from individuals with a venous ferritin < 75 ng/mL (data not

(CCC). 26 Concordance was considered perfect for CCC ≥ 0.99, sub-

shown). While the mean difference remained almost unchanged

stantial for 0.95 ≤ CCC <0.99, moderate for 0.90 ≤ CCC <0.95, and

(0.2 ng/mL), the upper and lower limits of agreement narrowed

poor for CCC < 0.90. 27 In addition, Bland-Altman analyses were per-

(–9.3 to + 9.6 ng/mL).

formed to determine mean bias as well as the upper and lower 95%

In order to account for differences in sampling sites, we com-

limits of agreement (LOA) between two methods, defined as mean

pared plasma ferritin measured with NoviplexTM cards to ferritin

difference ± 1.96 times the standard deviation. 28 To assess the clin-

measured from capillary blood samples, which showed moderate

ical relevance, differences between methods were compared with

concordance between the two methods (CCC = 0.91) with a mean

a recommended desirable specification for allowable total error of

bias of −10.7 ng/mL and limits of agreement ranging from −40.5 to

16.9%, as recommended for ferritin. 29

19.0 ng/mL. A total of 8 samples (40%) were outside of the recommended desirable range of 16.9% for the total error. The concordance
between capillary and venous samples was substantial (CCC = 0.96)

3 | R E S U LT S

with a mean bias of 9.9 ng/mL and limits of agreement ranging from
−8.2 to 27.9 ng/mL. The total error between plasma ferritin mea-

3.1 | Participants

sured from capillary and venous samples exceeded 16.9% in 4 samples (20%). When comparing agreement between duplicate ferritin

Twenty volunteers (10 male and 10 female) between 19 and 56 years

measures (Figure S1), concordance was considered substantial for

of age participated in this analysis (Table 1). Average participant age

venous (CCC = 0.97) and perfect for capillary (CCC > 0.99) samples.

and body mass index of our convenience sample were 28.5 ± 8.3 years
and 26.5 ± 5.3 kg/m2, respectively. The majority of participants were
white/Caucasian/European (65%), and the remaining participants

3.3 | Storage stability

were Asian (10%), Hispanic (10%), Black/African American (5%), and
mixed race (10%). One male participant had IDA (venous hemo-

The impact of storing the NoviplexTM card at room temperature for

globin < 13 g/dL and ferritin < 12 ng/mL). Three female participants

2 weeks prior to analysis on capillary ferritin is shown in Figure 3.

were considered iron deplete (venous ferritin between 12-25 ng/mL).

Overall, there was moderate concordance (CCC = 0.94) between

Iron overload, defined as venous ferritin > 200 ng/mL, was evident in

cards processed immediately and cards stored for 2 weeks. The

one male participant. All remaining participants fell within the nor-

mean bias was 10.5 ng/mL, with limits of agreement ranging from

mal ranges for hemoglobin and ferritin. Venous hemoglobin concen-

−15.4 to 36.5 ng/mL. Concordance between delayed analysis and

trations were significantly higher in male than in female participants

venous ferritin was good (CCC = 0.95) with a mean bias of −6.8 ng/

(P = .028), as was venous hematocrit (P = .019). Venous ferritin (P = .52)

mL and limits of agreement ranging from −31.1 to 17.5 ng/mL.

was not significantly different between male and female participants.

3.2 | Validity of ferritin measurements

3.4 | Impact of collection site on other
hematological parameters

Overall, there was substantial concordance (CCC = 0.96) between

When assessing the validity of other hematological parameters

TM

plasma ferritin measured with Noviplex

TA B L E 1

cards and the reference

measured from capillary blood, there was poor concordance for

Basic demographic and hematological parameters of our convenience sample (n = 20)
Age (y)

BMI (kg/m2)

Hemoglobin (g/dL)

Hematocrit (%)

Ferritin (ng/mL)

Men

25.6 ± 5.8

26.6 ± 4.1

14.7 ± 1.2

45.7 ± 3.5

85.6 ± 98.2

Women

31.4 ± 9.8

26.4 ± 6.5

13.7 ± 0.4

42.5 ± 1.6

62.9 ± 47.6
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F I G U R E 2 Left column: Agreement
between plasma ferritin measured
from blood samples collected from a
forearm vein, which served as reference
standard (venous ferritin), from samples
collected using the Noviplex™ Plasma
Prep Cards (Noviplex ferritin), and from
samples collected via capillary collection
into a tube (capillary collection). The
gray lines denote the lines of identity.
The solid black line depicts the linear
regression, and dashed lines indicate the
95% confidence intervals. Right column:
Bland-Altman analyses of plasma ferritin,
Noviplex ferritin, and capillary ferritin.
The dark gray line denotes the line of
identity. The solid black line depicts the
mean bias, and dashed lines indicate the
95% limits of agreement. The gray shaded
area indicates a desirable allowable total
error of 16.9% as suggested previously29

hemoglobin (CCC = 0.42) and hematocrit (CCC = 0.25) when com-

the latter indicating that the handheld device significantly underes-

pared to values obtained from venous blood measured with our

timated hematocrit.

laboratory-based hematology analyzer. Mean biases were 0.25 g/
dL (hemoglobin) and 2.86% (hematocrit) and limits of agreement
ranged between −0.77 and 1.27 g/dL (hemoglobin) and −0.4 and

4 | D I S CU S S I O N

6.2% (hematocrit). Concordance was similarly poor when comparing
the capillary hemoglobin (CCC = 0.44) and hematocrit (CCC = 0.45)

The overall goal of this proof-of-concept study was to evaluate

with values obtained from venous blood measured with the same

whether NoviplexTM Plasma Prep Cards, a novel blood collection

handheld analyzer. Mean biases were 0.37 g/dL (hemoglobin)

system, are suitable for minimally invasive screening of iron status.

and 1.0% (hematocrit) and limits of agreement ranged between

Our primary finding was that plasma concentrations of ferritin, when

−0.71 and 1.46 g/dL (hemoglobin) and −2.1 and 4.1% (hematocrit).

assessed from samples collected with the NoviplexTM cards, were in

Concordance between the handheld analyzer and the hematology

overall agreement with plasma ferritin assessed from samples ob-

analyzer using venous samples was improved but remained poor

tained via the gold standard method of venous blood collection, as

for hemoglobin (CCC = 0.87) and hematocrit (CCC = 0.76), as were

demonstrated by a substantial concordance (CCC = 0.96) and be-

mean biases (hemoglobin: −0.1 g/dL, hematocrit: 1.9%) and limits of

tween the two methods. While there was almost an identical con-

agreement (hemoglobin: −0.7 to 0.4 g/dL, hematocrit: 0.5 to 3.3%),

cordance with the reference standard for ferritin measured from

|
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F I G U R E 3 Left column: Agreement
between ferritin measured from blood
samples collected using the NoviplexTM
cards analyzed after storing the cards
for 2 wk at room temperature (delayed
analysis) with samples collected using the
NoviplexTM cards which were processed
immediately (immediate analysis) and with
ferritin measured from ferritin collected
from a forearm vein (venous ferritin).
The gray line denotes the line of identity.
The solid black line depicts the linear
regression, and dashed lines indicate
the 95% confidence intervals. Right
column: Bland-Altman analyses of delayed
analysis, immediate analysis, and venous
ferritin. The gray line denotes the line of
identity. The solid black line depicts the
mean bias, and dashed lines indicate the
95% limits of agreement

capillary samples (CCC = 0.96), NoviplexTM cards showed virtually

Another important finding of our study was that samples col-

no mean bias (−0.8 ng/mL), and classic capillary collection demon-

lected using the NoviplexTM were fairly stable over two weeks of

strated a mean bias of 9.9 ng/mL when compared with venous col-

storage at room temperature. Ferritin measured from cards stored

lection. This finding is in agreement with previous findings of slightly

at room temperature for 2 weeks demonstrated good concordance

elevated ferritin concentrations in capillary samples. 24 Since he-

when compared both to our reference method of venous samples

molysis is a common risk with capillary sample collection30 and can

processed immediately (CCC = 0.95) and to NoviplexTM cards ana-

lead to the leaking of ferritin from within red blood cells, where con-

lyzed immediately (CCC = 0.94). These findings are important to con-

centrations are much higher than in plasma,

20

it is possible that the

sider for the handling of samples, as there is no need for refrigeration.

slight elevation in ferritin in traditionally collected capillary samples

Using the NoviplexTM system, samples can be collected on-site and

is the result of contamination with cell-derived ferritin. With regard

subsequently sent to the laboratory for analysis, a procedure which is

to sampling sites, it is further important to note that hemoglobin

highly advantageous for in-field assessments. When combined with

and hematocrit values obtained from capillary samples showed only

the ease of sample collection, the substantially smaller sampling vol-

poor agreement with those from venous samples. While the validity

ume, and a lower risk of bruising and infections, this flexibility opens

of capillary hemoglobin and hematocrit was not the primary purpose

many new avenues for the iron status assessment in many different

of our study, our findings indicate that the collection of samples with

scenarios, such as athletes travelling to remote training and compe-

TM

Noviplex

card provide certain benefits over traditional capillary

tition sites. Despite the economic burden of iron status assessments
in elite athletes,17 wide-spread iron status screening to support an

blood collection into tubes.
TM

cards, namely the use of a smaller

athlete's health and performance is strongly advocated in the ath-

sample volume (~40 µL vs. 400 µL) and the eliminated need for pipet-

The benefits of the Noviplex

letic community.32 Even though there was overall good concordance

ting or other equipment (eg, centrifuge, refrigeration), mirror those

for cards stored at room temperature for 2 weeks, ferritin concen-

reported for dried blood spots. A recent study by Siart et al (2019)

trations were slightly reduced, as indicated by mean differences

assessed the use of dried blood spots for the assessment of inflam-

of 6.8 ng/mL (when compared to venous samples) and 10.5 ng/mL

matory markers in a group of 12 male individuals. And although their

(when compared to card analyzed immediately), a difference which

analysis included a large number of analytes, correlation coefficients

should be accounted for when making clinical decisions based solely

between venous concentrations and those obtained from dried

on samples stored for a prolonged period prior to analysis.

blood spots collected from capillary blood were smaller for all 92
analytes (< 0.9231) when compared to our results (r = .96).

Despite the substantial concordance and the virtually non-existent mean difference between ferritin measured from samples
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collected via the NoviplexTM system and samples collected via

capillary blood collection into collection tubes requiring sample pro-

venous sampling, it should be noted that 40% of the samples fell

cessing. The benefits of the NoviplexTM cards, which include a small

outside of the previously recommended desirable specification for

sample volume, easy sample processing and handling, the absence

allowable total error of 16.9%. 29 It is worth noting that the desir-

of expensive equipment (eg, centrifuge and refrigeration), and rela-

able range for the total error was exceeded primarily in samples with

tive stability over prolonged storage at room temperature make the

ferritin concentrations toward the lower end of the concentration

system suited for minimally invasive iron status screenings in the

range, where the allowable error is rather narrow. For samples in

field. Despite substantial concordance with venous blood collec-

the range of the cutoffs for IDA (12 ng/mL) and iron depletion (20-

tion, abnormal findings indicative of iron status abnormalities should

35 ng/mL),33 a total error of 16.9% equates to 2 ng/mL and 3-6 ng/

be confirmed in venous samples prior to the initiation of dietary or

TM

mL, respectively. If the Noviplex

system is only used as a screening

pharmacological interventions.

tool, implications of false-positive findings (ie, wrongly identifying a
person as iron depleted) are minor as long as confirmation analyses
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concordance for duplicate measures of venous ferritin from the
same sample (CCC = 0.97) was only slightly higher when compared
to the concordance of venous and Noviplex ferritin (CCC = 0.96).
Due to the small sample volume of the NoviplexTM plasma prep
cards of ~5 µL plasma, we were unable to conduct to measurements in duplicate, an approach which future studies may want to
pursue in order to minimize the analytical error.
The primary limitations of our study include its relatively small
sample size of 20 participants, who were recruited from a convenience sample rather than conducting the validation study in athletes or other groups at risk for iron status abnormalities. However,
given the high prevalence of iron depletion and IDA in these groups,
the wider range of ferritin concentrations from iron deficiency to
overload allowed us to test the validity of the NoviplexTM cards
across the entire ferritin range. Building on the findings of this
proof-of-concept study, the next step requires a full validation of the
collection method for ferritin and possibly other biomarkers of iron
status in a larger sample.

5 | CO N C LU S I O N S
The findings of this proof-of-concept study suggest that the
NoviplexTM cards offer a suitable alternative for the evaluation of
iron status as determined by plasma ferritin when compared to
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